High dose of Sanofi flu vaccine effective in trials

|About: Sanofi (SNY)|By:, SA News Editor

Sanofi's (SNY) influenza vaccine Fluzone High-Dose was 24.2% more effective in stopping people 65 years old and above from getting the flu than the standard dose of Fluzone in a large-scale trial.

With further testing still continuing, Sanofi expects to file a full clinical study to the FDA by early next year. (PR)